Biocryst Pharmaceuticals Inc (BCRX)
Operating Income Growth
230.57%
Quarterly · Period ending:
BCRX Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported230.57%period ending
Latest reported230.57%period ending
BCRX Quarterly Operating Income YoY % (-93.33% → 230.57%)
Year-over-year change
High-resolution chart · PNG
BCRX operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| 230.5748% | |
| -3,405.2151% | |
| 5,876.0648% | |
| 284.6984% | |
| 239.984% | |
| 246.5144% | |
| 89.4352% | |
| 164.5248% | |
| 142.3175% | |
| 49.0128% | |
| 7.8621% | |
| 31.6652% | |
| 40.375% | |
| 43.1211% | |
| 11.2425% | |
| 60.8716% | |
| -17.3754% | |
| 2.7639% | |
| 0.4351% | |
| -4.0127% | |
| 23.1836% | |
| -25.377% | |
| -47,977.9817% | |
| -22.1266% | |
| -10.287% | |
| -39.7136% | |
| 99.5685% | |
| -23.1811% | |
| -91.321% | |
| -32.0339% | |
| -41.4366% | |
| -113.4467% | |
| -17.627% | |
| -107.8989% | |
| -118.1363% | |
| -44.4541% | |
| -27.9143% | |
| 43.9049% | |
| 52.3787% | |
| 29.7903% | |
| -327.0685% | |
| -32.0028% | |
| -13.4468% | |
| -13.3678% | |
| 145.9764% | |
| -95.3696% | |
| -139.2801% | |
| -67.6534% | |
| 4.3074% | |
| -38.9391% | |
| 40.7761% | |
| 13.6103% | |
| -19.32% | |
| -6.2987% | |
| 3.1425% | |
| 37.3995% | |
| 28.5544% | |
| 56.5093% | |
| -7.1236% | |
| -16.515% | |
| -37.88% | |
| -321.3631% | |
| -168.3274% | |
| -2.7391% | |
| -18.2057% | |
| 70.9279% | |
| 53.8657% | |
| -11.7414% | |
| 34.6861% | |
| 33.0265% | |
| 386.0077% | |
| 19.2969% | |
| -76.4706% | |
| -1,389.7959% | |
| 68.0749% | |
| 27.93% | |
| 31.1728% | |
| 89.2688% | |
| -43.4034% | |
| -107.6321% | |
| -85.7047% | |
| -50.3774% | |
| -26.1243% | |
| -49.679% | |
| -17.3027% | |
| -6.7375% | |
| -82.6728% | |
| -55.3535% | |
| -43.7464% | |
| -95.911% | |
| -18.7965% | |
| 0.1757% | |
| 26.5093% | |
| 50.3561% | |
| -5.0397% | |
| -2,769.7479% | |
| -8,803.6364% | |
| -118.862% | |
| 50.2102% | |
| 95.5713% |